ArticleAmerican journal of translational research2024

GARNL3 identified as a crucial target for overcoming temozolomide resistance in EGFRvIII-positive glioblastoma.

Yun-Zhi Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.